BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu CH, Jassey A, Hsu HY, Lin LT. Antiviral Activities of Silymarin and Derivatives.Molecules. 2019;24. [PMID: 31010179 DOI: 10.3390/molecules24081552] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Sardanelli AM, Isgrò C, Palese LL. SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome. Molecules 2021;26:1409. [PMID: 33807773 DOI: 10.3390/molecules26051409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 MacDonald-Ramos K, Michán L, Martínez-Ibarra A, Cerbón M. Silymarin is an ally against insulin resistance: A review. Ann Hepatol 2021;23:100255. [PMID: 32950646 DOI: 10.1016/j.aohep.2020.08.072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Majeed A, Hussain W, Yasmin F, Akhtar A, Rasool N. Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies. Biomed Res Int 2021;2021:6661191. [PMID: 34095308 DOI: 10.1155/2021/6661191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mansouri K, Rastegari-Pouyani M, Ghanbri-Movahed M, Safarzadeh M, Kiani S, Ghanbari-Movahed Z. Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational. Biomed Pharmacother 2020;131:110694. [PMID: 32920511 DOI: 10.1016/j.biopha.2020.110694] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kesharwani SS, Jain V, Dey S, Sharma S, Mallya P, Kumar VA. An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin. Journal of Drug Delivery Science and Technology 2020;60:102021. [DOI: 10.1016/j.jddst.2020.102021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine 2021;85:153396. [PMID: 33380375 DOI: 10.1016/j.phymed.2020.153396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
7 Vargas-Mendoza N, García-Machorro J, Angeles-Valencia M, Martínez-Archundia M, Madrigal-Santillán EO, Morales-González Á, Anguiano-Robledo L, Morales-González JA. Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals. World J Gastroenterol 2021;27:5630-65. [PMID: 34629792 DOI: 10.3748/wjg.v27.i34.5630] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Anand AV, Balamuralikrishnan B, Kaviya M, Bharathi K, Parithathvi A, Arun M, Senthilkumar N, Velayuthaprabhu S, Saradhadevi M, Al-Dhabi NA, Arasu MV, Yatoo MI, Tiwari R, Dhama K. Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2. Molecules 2021;26:1775. [PMID: 33809963 DOI: 10.3390/molecules26061775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Raza ZA, Taqi M, Tariq MR. Antibacterial agents applied as antivirals in textile-based PPE: a narrative review. The Journal of The Textile Institute. [DOI: 10.1080/00405000.2021.1889166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sayed AM, Hassanein EH, Salem SH, Hussein OE, Mahmoud AM. Flavonoids-mediated SIRT1 signaling activation in hepatic disorders. Life Sciences 2020;259:118173. [DOI: 10.1016/j.lfs.2020.118173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
11 Bosch-Barrera J, Roqué A, Teixidor E, Carmona-Garcia MC, Arbusà A, Brunet J, Martin-Castillo B, Cuyàs E, Verdura S, Menendez JA. Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin. Pharmaceuticals (Basel) 2021;15:19. [PMID: 35056076 DOI: 10.3390/ph15010019] [Reference Citation Analysis]
12 Parthasarathy A, Borrego EJ, Savka MA, Dobson RCJ, Hudson AO. Amino acid-derived defense metabolites from plants: A potential source to facilitate novel antimicrobial development. J Biol Chem 2021;296:100438. [PMID: 33610552 DOI: 10.1016/j.jbc.2021.100438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Thongsri P, Pewkliang Y, Borwornpinyo S, Wongkajornsilp A, Hongeng S, Sa-Ngiamsuntorn K. Curcumin inhibited hepatitis B viral entry through NTCP binding. Sci Rep 2021;11:19125. [PMID: 34580340 DOI: 10.1038/s41598-021-98243-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cui Q, Du R, Liu M, Rong L. Lignans and Their Derivatives from Plants as Antivirals. Molecules 2020;25:E183. [PMID: 31906391 DOI: 10.3390/molecules25010183] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
15 Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA. Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. J Clin Med 2020;9:E1770. [PMID: 32517353 DOI: 10.3390/jcm9061770] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
16 Delmas D. Silymarin and Derivatives: From Biosynthesis to Health Benefits. Molecules 2020;25:E2415. [PMID: 32455869 DOI: 10.3390/molecules25102415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Loutfy SA, Abdel-Salam AI, Moatasim Y, Gomaa MR, Abdel Fattah NF, Emam MH, Ali F, ElShehaby HA, Ragab EA, Alam El-Din HM, Mostafa A, Ali MA, Kasry A. Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil-CNPs) against SARS-CoV-2 (in silico and in vitro study). RSC Adv 2022;12:15775-86. [PMID: 35685696 DOI: 10.1039/d2ra00905f] [Reference Citation Analysis]
18 Křen V, Valentová K. Silybin and its congeners: from traditional medicine to molecular effects. Nat Prod Rep 2022. [PMID: 35510639 DOI: 10.1039/d2np00013j] [Reference Citation Analysis]
19 Poltavets YI, Kuznetsov SL, Tubasheva IA, Murav’eva AI, Gukasova NV. Nano- and Microsized Forms of Silymarin and Silybin. Nanotechnol Russia 2021;16:115-37. [DOI: 10.1134/s2635167621020105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Li S, Zhang Q, Ding Y, Wang X, Liu P. Flavonoids ameliorate aluminum chloride-induced learning and memory impairments via suppression of apoptosis and oxidative stress in rats. J Inorg Biochem 2020;212:111252. [PMID: 32950828 DOI: 10.1016/j.jinorgbio.2020.111252] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Kashyap D, Roy R, Kar P, Jha HC. Plant-derived active compounds as a potential nucleocapsid protein inhibitor of SARS-CoV-2: an in-silico study. J Biomol Struct Dyn 2022;:1-16. [PMID: 35532092 DOI: 10.1080/07391102.2022.2072951] [Reference Citation Analysis]
22 Palit P, Mukhopadhyay A, Chattopadhyay D. Phyto-pharmacological perspective of Silymarin: A potential prophylactic or therapeutic agent for COVID-19, based on its promising immunomodulatory, anti-coagulant and anti-viral property. Phytother Res 2021;35:4246-57. [PMID: 33817867 DOI: 10.1002/ptr.7084] [Reference Citation Analysis]
23 Křen V. Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners. Int J Mol Sci 2021;22:7885. [PMID: 34360650 DOI: 10.3390/ijms22157885] [Reference Citation Analysis]
24 de Freitas CS, Rocha MEN, Sacramento CQ, Marttorelli A, Ferreira AC, Rocha N, de Oliveira AC, de Oliveira Gomes AM, Dos Santos PS, da Silva EO, da Costa JP, de Lima Moreira D, Bozza PT, Silva JL, Barroso SPC, Souza TML. Agathisflavone, a Biflavonoid from Anacardium occidentale L., Inhibits Influenza Virus Neuraminidase. Curr Top Med Chem 2020;20:111-20. [PMID: 31854280 DOI: 10.2174/1568026620666191219150738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Wei X, Ruan W, Vrieling K. Current Knowledge and Perspectives of Pyrrolizidine Alkaloids in Pharmacological Applications: A Mini-Review. Molecules 2021;26:1970. [PMID: 33807368 DOI: 10.3390/molecules26071970] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Eita AAB. Milk thistle (Silybum marianum (L.)Gaertn.): An overview about its pharmacology and medicinal uses with an emphasis on oral diseases. J Oral Biosci 2021:S1349-0079(21)00181-X. [PMID: 34968721 DOI: 10.1016/j.job.2021.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Xu Y, Li J, He B, Feng T, Liang L, Huang X. In vitro Dissolution Testing and Pharmacokinetic Studies of Silymarin Solid Dispersion After Oral Administration to Healthy Pigs. Front Vet Sci 2022;9:815198. [DOI: 10.3389/fvets.2022.815198] [Reference Citation Analysis]
28 Naik B, Mattaparthi VSK, Gupta N, Ojha R, Das P, Singh S, Prajapati VK, Prusty D. Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications. J Biomol Struct Dyn 2021;:1-25. [PMID: 34062110 DOI: 10.1080/07391102.2021.1931451] [Reference Citation Analysis]
29 Gogulski M, Cieślak A, Grabska J, Ardois M, Pomorska-Mól M, Kołodziejski PA, Libera K, Strompfová V, Szumacher-Strabel M. Effects of silybin supplementation on nutrient digestibility, hematological parameters, liver function indices, and liver-specific mi-RNA concentration in dogs. BMC Vet Res 2021;17:228. [PMID: 34174886 DOI: 10.1186/s12917-021-02929-3] [Reference Citation Analysis]